Instructor, Medicine, UCLA School of Medicine
Gastroenterology
Dr. Michael J. Mendoza, MD
Michael Mendoza is an expert in the field of Gastroenterology. He graduated from David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Michael Mendoza accepts Medicare.
Schools
University of California At Los Angeles
University of California At San Francisco
Procedures Preformed
- Anoscopy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
Accepted Insurances
- Aetna
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select PPO
- Basic Exclusive PPO for Small Business
- Basic PPO
- Commercial Insurance Company
- Delta Health System
- First Health (Coventry Health Care) PPO
- GEHA
- Medicaid
- Medicare MCR
- Tricare
- United Healthcare
- Wisconsin Physicians Service
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCLA Medical Center
-
David Geffen School of Medicine at UCLA
Drug Facts
NPI NUMBER |
|
1902989668 |
NPPES Provider LastName |
|
MENDOZA |
NPPES Provider FirstName |
|
MICHAEL |
NPPES Provider ZIPCode |
|
939407849 |
NPPES Provider State |
|
CA |
Specialty Description |
|
Gastroenterology |
Total Claim Count |
|
329.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1902989668 |
Last Name Of The Provider |
MENDOZA |
First Name Of The Provider |
MICHAEL |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog